(Q45861457)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Edward M. Conway

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Jenny Persson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Van de Wouwer M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

De Vriese A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Waelkens E

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Collen D

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Daha MR

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879225%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thrombosis and Haemostasis

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

1813-1824

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879225%20AND%20SRC:MED&resulttype=core&format=json

Elevation of activated protein C in synovial joints in rheumatoid arthritis and its correlation with matrix metalloproteinase 2

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Role of the tissue factor pathway in synovial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Effect of thrombin inhibition on synovial inflammation in antigen induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Crosstalk between inflammation and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Thrombin Activatable Fibrinolysis Inhibitor, a Potential Regulator of Vascular Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Arthritogenic monoclonal antibodies from K/BxN mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Efficient selection for high-expression transfectants with a novel eukaryotic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

The role of complement activation in tumour necrosis factor-induced lethal hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Structural and functional aspects of C1-inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Damage control in rheumatoid arthritis. Hard-hitting, early treatment is crucial to curbing joint destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Raising expectations for arthritis treatment. Biologic response modifiers are making remission possible

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

The impact of new biologicals in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Cardiovascular risk and COX-2 inhibition in rheumatological practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

The role of macrophages in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

HMGB1 is a potent trigger of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

HMGB1, a pro-inflammatory cytokine of clinical interest: introduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Proteases of the complement system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

The regulation of the complement system: insights from genetically-engineered mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

Biological effects of C1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X

High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.02033.X